Advertisement

Reactions Weekly

, Volume 1196, Issue 1, pp 4–4 | Cite as

The US FDA has issued an early communication about its ongoing safety review of abacavir [Ziagen] and didanosine [Videx]

Media release
  • 10 Downloads

Keywords

Public Health Adverse Event Data Collection Heart Disease Reverse Transcriptase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    FDA.Early Communication about an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine). Media Release: 27 Mar 2008. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations